172 related articles for article (PubMed ID: 38285100)
1. Predictive tissue markers in testicular germ cell tumors: Immunohistochemical expression of MLH1 and REV-7 proteins.
Spinos T; Zografos E; Koutsoukos K; Zagouri F; Kosmas C; Driva TS; Goutas D; Gakiopoulou C; Agrogiannis G; Theochari E; Tzavara C; Lazaris AC
Int Urol Nephrol; 2024 Jun; 56(6):1887-1898. PubMed ID: 38285100
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression.
Saeednejad Zanjani L; Razmi M; Fattahi F; Kalantari E; Abolhasani M; Saki S; Madjd Z; Mohsenzadegan M
J Cancer Res Clin Oncol; 2022 Mar; 148(3):609-631. PubMed ID: 34837545
[TBL] [Abstract][Full Text] [Related]
3. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD44 is associated with aggressiveness in seminomas.
Labropoulou VT; Manou D; Ravazoula P; Alzahrani FM; Kalofonos HP; Theocharis AD
Mol Biol Rep; 2024 May; 51(1):693. PubMed ID: 38796656
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors.
Cierna Z; Mego M; Miskovska V; Machalekova K; Chovanec M; Svetlovska D; Hainova K; Rejlekova K; Macak D; Spanik S; Ondrus D; Kajo K; Mardiak J; Babal P
Ann Oncol; 2016 Feb; 27(2):300-5. PubMed ID: 26598537
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of immunohistochemistry and FISH for chromosome 12p in type Ⅱ testicular germ cell tumors].
Shen Q; Rao Q; Yu B; Xia QY; Bao W; Lu ZF; Shi QL; Zhou XJ
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):692-697. PubMed ID: 29019224
[TBL] [Abstract][Full Text] [Related]
7. PCPH expression is an early event in the development of testicular germ cell tumors.
Regadera J; Blánquez MJ; González-Peramato P; Nistal M; Miller JC; Tirado OM; Notario V
Int J Oncol; 2006 Mar; 28(3):595-604. PubMed ID: 16465363
[TBL] [Abstract][Full Text] [Related]
8. Frequent PD-L1 expression in testicular germ cell tumors.
Fankhauser CD; Curioni-Fontecedro A; Allmann V; Beyer J; Tischler V; Sulser T; Moch H; Bode PK
Br J Cancer; 2015 Jul; 113(3):411-3. PubMed ID: 26171934
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors.
Kamoshida S; Satoh Y; Yasuda M; Kajiwara H; Tsukinoki K; Osamura RY
Oncol Rep; 2002; 9(4):845-51. PubMed ID: 12066220
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors.
Chovanec M; Cierna Z; Miskovska V; Machalekova K; Svetlovska D; Kalavska K; Rejlekova K; Spanik S; Kajo K; Babal P; Mardiak J; Mego M
Oncotarget; 2017 Mar; 8(13):21794-21805. PubMed ID: 28423520
[TBL] [Abstract][Full Text] [Related]
11. Nucleolin and nucleophosmin expression in seminomas and non-seminomatous testicular tumors.
Masiuk M; Lewandowska M; Teresinski L; Dobak E; Urasinska E
Folia Histochem Cytobiol; 2019; 57(3):139-145. PubMed ID: 31513277
[TBL] [Abstract][Full Text] [Related]
12. Germ cell tumors of the mediastinum and testis: a comparative immunohistochemical study of 120 cases.
Suster S; Moran CA; Dominguez-Malagon H; Quevedo-Blanco P
Hum Pathol; 1998 Jul; 29(7):737-42. PubMed ID: 9670832
[TBL] [Abstract][Full Text] [Related]
13. Recent developments in testicular germ cell tumor research.
van de Geijn GJ; Hersmus R; Looijenga LH
Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
[TBL] [Abstract][Full Text] [Related]
14. Expression of syndecan-4 and correlation with metastatic potential in testicular germ cell tumours.
Labropoulou VT; Skandalis SS; Ravazoula P; Perimenis P; Karamanos NK; Kalofonos HP; Theocharis AD
Biomed Res Int; 2013; 2013():214864. PubMed ID: 23844358
[TBL] [Abstract][Full Text] [Related]
15. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
16. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
[TBL] [Abstract][Full Text] [Related]
17. Expression of cellular apoptosis susceptibility (CAS) in the human testis and testicular germ cell tumors.
Liu J; Ye M; Han R; Gui Y; Li X; Zhang H; Wang X; Guo H; Li F; Zhao AZ; Guan K; Chen H
Med Oncol; 2019 May; 36(7):61. PubMed ID: 31140031
[TBL] [Abstract][Full Text] [Related]
18. In Search of TGCT Biomarkers: A Comprehensive
Raos D; Krasic J; Masic S; Abramovic I; Coric M; Kruslin B; Katusic Bojanac A; Bulic-Jakus F; Jezek D; Ulamec M; Sincic N
Dis Markers; 2020; 2020():8841880. PubMed ID: 33224314
[TBL] [Abstract][Full Text] [Related]
19. Gene expression microarray analysis of adult testicular germ cell tumor: a comparison between pure-type seminomas and seminoma components in mixed tumors.
Miyai K; Yonekura Y; Ito K; Matsukuma S; Tsuda H
Virchows Arch; 2021 Dec; 479(6):1177-1186. PubMed ID: 34347114
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.
Hinz S; Magheli A; Weikert S; Schulze W; Krause H; Schrader M; Miller K; Kempkensteffen C
World J Urol; 2010 Oct; 28(5):631-5. PubMed ID: 20043168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
